NeuroPace Inc [NPCE] stock is trading at $10.25, up 0.49%. An important factor to consider is whether the stock is rising or falling in short-term value. The NPCE shares have gain 11.53% over the last week, with a monthly amount glided 57.94%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
NeuroPace Inc [NASDAQ: NPCE] stock has seen the most recent analyst activity on March 14, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $20 from $16. Previously, Leerink Partners started tracking the stock with Outperform rating on January 30, 2024, and set its price target to $22. On November 10, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $11 on the stock. Morgan Stanley upgraded its rating to a Equal-Weight and increased its price target to $6 on August 24, 2023. Lake Street initiated its recommendation with a Buy and recommended $10 as its price target on February 22, 2023. Wolfe Research started tracking with a Outperform rating for this stock on April 06, 2022, and assigned it a price target of $13. In a note dated January 19, 2022, Wells Fargo downgraded an Equal Weight rating on this stock but restated the target price of $11.
NeuroPace Inc [NPCE] stock has fluctuated between $5.45 and $18.15 over the past year. Currently, Wall Street analysts expect the stock to reach $12.88 within the next 12 months. NeuroPace Inc [NASDAQ: NPCE] shares were valued at $10.25 at the most recent close of the market. An investor can expect a potential return of 25.66% based on the average NPCE price forecast.
Analyzing the NPCE fundamentals
NeuroPace Inc [NASDAQ:NPCE] reported sales of 76.45M for the trailing twelve months, which represents a growth of 28.20%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.3%, Pretax Profit Margin comes in at -0.37%, and Net Profit Margin reading is -0.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -2.05 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 6.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.87 points at the first support level, and at 9.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.54, and for the 2nd resistance point, it is at 10.84.
Ratios To Look Out For
For context, NeuroPace Inc’s Current Ratio is 5.59. On the other hand, the Quick Ratio is 4.77, and the Cash Ratio is 1.04. Considering the valuation of this stock, the price to sales ratio is 4.00, the price to book ratio is 31.07.
Transactions by insiders
Recent insider trading involved KCK LTD., 10% Owner, that happened on Oct 25 ’24 when 0.22 million shares were sold. 10% Owner, KCK LTD. completed a deal on Oct 23 ’24 to sell 147.0 shares. Meanwhile, 10% Owner KCK LTD. bought 0.22 million shares on Oct 25 ’24.
